PEP three-lens brief
Evidence-based stock research on PEP. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
50-day MA below 200-day MA (death-cross regime); price below both. · Trading at 9% of its 52-week range — deep in the lower band.
- Trading at 9% of its 52-week range — deep in the lower band.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- Analyst mean target $162.82 — 19% above current (22 analysts).
- Debt-to-equity of 245% — balance-sheet-heavy.
- Reported earnings on 2026-07-09.
PEP closed at $137.22 (-0.46%) as of 2026-07-10. Market cap: $187.44B. P/E (trailing) 18.0. Price is below the 50-day MA and below the 200-day MA. Positives: analyst mean target $162.82 — 19% above current (22 analysts).. Concerns: trading at 9% of its 52-week range — deep in the lower band.; 50-day MA below 200-day MA (death-cross regime); price below both.. Last quarter: Revenue $19.44B, net income $2.33B, free cash flow $8.75B. Watching for: 2026-07-16 earnings release (5 days out).
Why three lenses on PEP, not one.
A single reasoning model has blind spots it doesn’t know about. We examine PEPacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/PEP" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath PEP brief"></iframe>